The 2025 Medtech Market Outlook - GLP 1

GLP-1 Concerns Have Slimmed. The industry concerns over the impact of GLP-1s have abated. Seen as a potential disruptor to several device markets, challenges with their use have decreased the severity of their initial projected disruption on the medtech industry. ​​Exclusive data and insights on what's happening in the Medtech industry in 2025 from LSI's Market Intelligence team.

LSI Asia ‘25 is filling fast. Secure your spot today to join Medtech and Healthtech leaders.

June 10th - 13th, 2025The Ritz-Carlton, Millenia Singapore Register arrow